PharmaGambit launches Three Moves Ahead podcast on Spotify and YouTube

PharmaGambit has launched a new podcast, Three Moves Ahead, on Spotify and YouTube to help pharma teams stress-test launch plans and anticipate competitor responses. The first episode looks at why stronger clinical data does not always translate into commercial success.

Why it matters: - Pharma launch teams face pressure well beyond clinical data, including payer behavior, prescriber response and competitor moves. - Three Moves Ahead is built to help pharma professionals spot strategy gaps before a launch reaches the market. - The podcast targets people working in pharmaceutical marketing, launch strategy, market access and commercial leadership.

What happened: - PharmaGambit introduced PharmaGambit – Three Moves Ahead, a new podcast available on Spotify and YouTube. - The podcast is hosted by Alexis Besson and Simon Fogg. - The launch was announced in London on Oct. 21, 2026. - The series is designed around pharmaceutical strategic simulation and competitive wargaming.

The details: - The first full episode examines the belief that stronger clinical data automatically leads to market victory. - The episode uses the statin wars and the evolving GLP-1 market as examples of how commercial outcomes can differ from clinical performance. - The hosts discuss how market access, customer behavior and competitive strategy can shape launch results. - Alexis Besson said the podcast aims to help pharma leaders challenge assumptions and prepare for competitor, payer and prescriber responses before those responses hit the market. - The opening episode also looks at why clinically differentiated medicines can still struggle commercially. - The series examines how stakeholder behavior can alter a launch trajectory. - The podcast explores what earlier pharmaceutical markets can teach teams preparing for new competition. - PharmaGambit says strategic simulation can reveal vulnerabilities that internal planning discussions may miss. - The company says teams can use simulations to consider how competitors, healthcare professionals and payers may respond. - The Spotify episode link is Listen on Spotify. - The YouTube channel link is Watch on YouTube. - PharmaGambit's LinkedIn page is Follow PharmaGambit on LinkedIn.

Between the lines: - The podcast is positioned as a practical counterweight to internal launch optimism. - PharmaGambit is framing strategic simulation as a way to pressure-test commercial assumptions, not just clinical positioning. - The emphasis on competitor, payer and prescriber reactions suggests the series is aimed at teams that need to prepare for market friction, not just product approval.

What's next: - PharmaGambit is inviting pharmaceutical professionals to listen, watch and join the conversation around the assumptions driving strategic decisions. - The podcast is likely to continue focusing on launch planning, market access and competitive response scenarios. - Future episodes may extend the same simulation-based approach to other commercial questions facing pharma teams.

The bottom line: - PharmaGambit is using a podcast format to push a simple message: in pharma, winning the launch depends on anticipating the market, not just proving the science.